Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients

Abstract Introduction Early detection of heart failure (HF), particularly in asymptomatic individuals, is essential for timely intervention. This study aimed to determine the prevalence of HF among high‐risk individuals in primary care using N‐terminal probrain natriuretic peptide (NT‐proBNP) screen...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmet Celik, Emrah Yesil, Unal Kılıç, Gizem Akcay Ozyurt, Selman Aytimur, Mustafa Demir, Huseyin Naci Eker, Ayse Siddika Col, Cemil Ilker Altiparmak, Mustafa Ergen, Selen Bozkaya, Ismail Sefa Okyay, Ibrahim Ethem Kerem, Kiristin Marina Arap, Melike Yirtar, Deniz Korkmaz, Ali Kırdağ, Ismail Turkay Ozcan
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.15290
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849316434561204224
author Ahmet Celik
Emrah Yesil
Unal Kılıç
Gizem Akcay Ozyurt
Selman Aytimur
Mustafa Demir
Huseyin Naci Eker
Ayse Siddika Col
Cemil Ilker Altiparmak
Mustafa Ergen
Selen Bozkaya
Ismail Sefa Okyay
Ibrahim Ethem Kerem
Kiristin Marina Arap
Melike Yirtar
Deniz Korkmaz
Ali Kırdağ
Ismail Turkay Ozcan
author_facet Ahmet Celik
Emrah Yesil
Unal Kılıç
Gizem Akcay Ozyurt
Selman Aytimur
Mustafa Demir
Huseyin Naci Eker
Ayse Siddika Col
Cemil Ilker Altiparmak
Mustafa Ergen
Selen Bozkaya
Ismail Sefa Okyay
Ibrahim Ethem Kerem
Kiristin Marina Arap
Melike Yirtar
Deniz Korkmaz
Ali Kırdağ
Ismail Turkay Ozcan
author_sort Ahmet Celik
collection DOAJ
description Abstract Introduction Early detection of heart failure (HF), particularly in asymptomatic individuals, is essential for timely intervention. This study aimed to determine the prevalence of HF among high‐risk individuals in primary care using N‐terminal probrain natriuretic peptide (NT‐proBNP) screening. Methods A prospective cohort of 874 participants aged ≥40 years with at least one HF risk factor but no prior HF diagnosis was analysed. NT‐proBNP levels were measured, and all participants underwent comprehensive cardiac evaluations, including laboratory tests, electrocardiography and echocardiography. Results The mean age of the cohort was 62.5 ± 9.1 years, and 51.9% were female. Based on ACC/AHA HF staging, 69.1% of participants were classified as Stage A, 21.9% as Stage B and 9.0% as Stage C. Elevated NT‐proBNP levels were detected in 84.8% of Stage B and 100% of Stage C patients. Among Stage C patients, 92.4% had HF with preserved ejection fraction (HFpEF). NT‐proBNP levels correlated positively with left atrial volume index (r = 0.273, P < 0.001), left ventricular mass index (r = 0.207, P < 0.001), E/e′ ratio (r = 0.182, P < 0.001) and estimated systolic pulmonary artery pressure (r = 0.124, P < 0.001), while showing a negative correlation with estimated glomerular filtration rate (r = −0.222, P < 0.001). Conclusions A significant proportion of high‐risk individuals in primary care had undiagnosed HF, particularly Stage B (pre‐HF) and early symptomatic Stage C HF. The predominance of HFpEF highlights the need for targeted management. NT‐proBNP screening is a valuable tool for early identification and risk stratification, especially for detecting Stage B HF, where it serves as an effective standalone method in the absence of imaging.
format Article
id doaj-art-d2df4294f2ef43c995dfe461affe8066
institution Kabale University
issn 2055-5822
language English
publishDate 2025-08-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj-art-d2df4294f2ef43c995dfe461affe80662025-08-20T03:51:44ZengWileyESC Heart Failure2055-58222025-08-011242834284210.1002/ehf2.15290Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patientsAhmet Celik0Emrah Yesil1Unal Kılıç2Gizem Akcay Ozyurt3Selman Aytimur4Mustafa Demir5Huseyin Naci Eker6Ayse Siddika Col7Cemil Ilker Altiparmak8Mustafa Ergen9Selen Bozkaya10Ismail Sefa Okyay11Ibrahim Ethem Kerem12Kiristin Marina Arap13Melike Yirtar14Deniz Korkmaz15Ali Kırdağ16Ismail Turkay Ozcan17Department of Cardiology, Faculty of Medicine Mersin University Mersin TurkeyDepartment of Cardiology, Faculty of Medicine Mersin University Mersin TurkeyMersin Ticaret Borsasi Primary Health Care Center Mersin TurkeyDepartment of Cardiology, Faculty of Medicine Mersin University Mersin TurkeyDepartment of Cardiology, Faculty of Medicine Mersin University Mersin TurkeyDepartment of Cardiology, Faculty of Medicine Mersin University Mersin TurkeyMersin Central Primary Health Care Center Mersin TurkeyMersin Mimar Sinan Primary Health Care Center Mersin TurkeyMersin Ticaret Borsasi Primary Health Care Center Mersin TurkeyMersin Toroslar Osmaniye Primary Health Care Center Mersin TurkeyMersin Gazi Primary Health Care Center Mersin TurkeyMersin Mezitli Sahil Primary Health Care Center Mersin TurkeyMersin Ticaret Borsasi Primary Health Care Center Mersin TurkeyMersin Mimar Sinan Primary Health Care Center Mersin TurkeyMersin Osman Gazi Primary Health Care Center Mersin TurkeyMersin Ciftlikkoy Primary Health Care Center Mersin TurkeyMersin Selahattin Yanpar Primary Health Care Center Mersin TurkeyDepartment of Cardiology, Faculty of Medicine Mersin University Mersin TurkeyAbstract Introduction Early detection of heart failure (HF), particularly in asymptomatic individuals, is essential for timely intervention. This study aimed to determine the prevalence of HF among high‐risk individuals in primary care using N‐terminal probrain natriuretic peptide (NT‐proBNP) screening. Methods A prospective cohort of 874 participants aged ≥40 years with at least one HF risk factor but no prior HF diagnosis was analysed. NT‐proBNP levels were measured, and all participants underwent comprehensive cardiac evaluations, including laboratory tests, electrocardiography and echocardiography. Results The mean age of the cohort was 62.5 ± 9.1 years, and 51.9% were female. Based on ACC/AHA HF staging, 69.1% of participants were classified as Stage A, 21.9% as Stage B and 9.0% as Stage C. Elevated NT‐proBNP levels were detected in 84.8% of Stage B and 100% of Stage C patients. Among Stage C patients, 92.4% had HF with preserved ejection fraction (HFpEF). NT‐proBNP levels correlated positively with left atrial volume index (r = 0.273, P < 0.001), left ventricular mass index (r = 0.207, P < 0.001), E/e′ ratio (r = 0.182, P < 0.001) and estimated systolic pulmonary artery pressure (r = 0.124, P < 0.001), while showing a negative correlation with estimated glomerular filtration rate (r = −0.222, P < 0.001). Conclusions A significant proportion of high‐risk individuals in primary care had undiagnosed HF, particularly Stage B (pre‐HF) and early symptomatic Stage C HF. The predominance of HFpEF highlights the need for targeted management. NT‐proBNP screening is a valuable tool for early identification and risk stratification, especially for detecting Stage B HF, where it serves as an effective standalone method in the absence of imaging.https://doi.org/10.1002/ehf2.15290NT‐proBNPHFpEFprimary careStage AStage BStage C
spellingShingle Ahmet Celik
Emrah Yesil
Unal Kılıç
Gizem Akcay Ozyurt
Selman Aytimur
Mustafa Demir
Huseyin Naci Eker
Ayse Siddika Col
Cemil Ilker Altiparmak
Mustafa Ergen
Selen Bozkaya
Ismail Sefa Okyay
Ibrahim Ethem Kerem
Kiristin Marina Arap
Melike Yirtar
Deniz Korkmaz
Ali Kırdağ
Ismail Turkay Ozcan
Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients
ESC Heart Failure
NT‐proBNP
HFpEF
primary care
Stage A
Stage B
Stage C
title Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients
title_full Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients
title_fullStr Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients
title_full_unstemmed Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients
title_short Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients
title_sort exploring heart failure prevalence and dimensions a comprehensive nt probnp study in high risk primary care patients
topic NT‐proBNP
HFpEF
primary care
Stage A
Stage B
Stage C
url https://doi.org/10.1002/ehf2.15290
work_keys_str_mv AT ahmetcelik exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT emrahyesil exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT unalkılıc exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT gizemakcayozyurt exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT selmanaytimur exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT mustafademir exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT huseyinnacieker exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT aysesiddikacol exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT cemililkeraltiparmak exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT mustafaergen exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT selenbozkaya exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT ismailsefaokyay exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT ibrahimethemkerem exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT kiristinmarinaarap exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT melikeyirtar exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT denizkorkmaz exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT alikırdag exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients
AT ismailturkayozcan exploringheartfailureprevalenceanddimensionsacomprehensiventprobnpstudyinhighriskprimarycarepatients